LATE-BREAKING ABSTRACT: A feasibility and safety study, of bronchoscopic hot saline ablation (BHSA) of emphysematous lung. A different emphysema therapy

D. Stav, N. Natiff, I. Shpirer (beer Yaakov, Israel)

Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Session: Bronchoscopic treatment of COPD and asthma: where are we going?
Session type: Thematic Poster Session
Number: 2280
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Stav, N. Natiff, I. Shpirer (beer Yaakov, Israel). LATE-BREAKING ABSTRACT: A feasibility and safety study, of bronchoscopic hot saline ablation (BHSA) of emphysematous lung. A different emphysema therapy. Eur Respir J 2013; 42: Suppl. 57, 2280

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Preliminary results of study of bronchoscopic hot saline ablation (BHSA) treatment, in emphysematous lung disease
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015


Patient selection and efficacy of valve bronchoscopic lung volume reduction (BLVR) in emphysema
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016

Bronchoscopic lung volume reduction with coils (BLVR-Coils) for treatment of patients with severe heterogeneous emphysema and bilaterally incomplete fissures. Its effectiveness in everyday endoscopic practice
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013


Endoscopic lung volume reduction (ELVR) in COPD: A comparison between two endobronchial valves systems
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013


Targeted vapor ablation as a new method for endoscopic lung volume reduction at segmental level
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016


6 and 12 month outcomes following RePneu bronchoscopic lung volume reduction coil treatment
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013


Endoscopic lung volume reduction with nitinol coils in very severe emphysema: Mid-term effectiveness vs. disease related continuous loss of lung function
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015

Survival benefit from successful bronchoscopic lung volume reduction with endobronchial valves - A 10 year follow up study
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016

Safety and efficacy of emphysematous lung sealant (ELS) therapy for advanced emphysema out to 2 years
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013


A single center experience with lung volume reduction coil (LVR-coil) treatment of patients with advanced emphysema. Effectiveness and complications after 1 year
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016

Endobronchial microbiological colonisation in stable COPD patients with severe emphysema undergoing endoscopic lung volume reduction.
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017

Severe heterogeneous emphysema treated unilaterally with endobronchial coils in patients with bilaterally incomplete fissures. Aiming for long lasting endoscopic lung volume reduction (ELVR); is effectiveness sustained at one year follow-up?
Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other
Year: 2014

Effectiveness and complications of endobronchial coil treatment for lung volume reduction (LVRC) in patients with severe heterogeneous emphysema and bilateral incomplete fissures
Source: International Congress 2014 – Bronchoscopic treatment of emphysema: where are we?
Year: 2014

Bronchoscopic lung volume reduction with endobronchial valves improves exercise capacity but not oxygen uptake kinetics in a group of patients with severe emphysema
Source: Annual Congress 2013 –Mechanisms contributing to exercise limitation in health and respiratory, cardiac and pulmonary vascular diseases
Year: 2013

Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema
Source: Eur Respir J 2012; 39: 1326-1333
Year: 2012



Endobronchial valve placement as a treatment of persistent pulmonary air leak
Source: International Congress 2016 – Bronchoscopy: from diagnostic to treating air leaks
Year: 2016


Echocardiogram parameters in patients with COPD in the year after endoscopic lung volume reduction (ELVR)
Source: International Congress 2015 – Bronchoscopic treatment of emphysema and asthma: what is new?
Year: 2015


Correlation between patients' background and the therapeutic effect of BLVR using EMV (endobronchial Miyazawa valve)
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013


CT predictors of response to endobronchial valve lung reduction treatment: Comparison with Chartis pulmonary assessment system
Source: International Congress 2014 – Bronchoscopic treatment of emphysema: where are we?
Year: 2014

Long-term outcomes in 35 patients with emphysema after endoscopic lung volume reduction (ELVR) with valves
Source: International Congress 2014 – New trends in bronchoscopy: EBUS-TBNA and endoscopic treatment of emphysema
Year: 2014